Carealytix
About Carealytix
Carealytix is dedicated to transforming chronic disease management through user-centric technology and digital products designed for personalized care.
They collaborate with healthcare providers, payers, researchers, and industry partners to advance tech-enabled, interdisciplinary chronic care.
What Carealytix Does
Carealytix develops a digital care platform focused on kidney care as well as chronic condition management. Their notable products include Mizu, a personal CKD companion app with over 25,000 registered users, and Kidney+, a telecoaching hybrid care program specializing in supporting patients with diagnosed kidney disease between regular doctor's visits.
The company emphasizes regulatory compliance, being ISO-13485 certified, GDPR compliant, and compliant with the EU Medical Device Regulation (EU-MDR) for software-as-medical-device.
Value Created
Carealytix's solutions aim to streamline patient-physician interactions, improve clinical workflow efficiency, enable patient engagement, accelerate clinical research, and enable data-driven personalized care to reduce the burden of chronic diseases.
Their modular platform addresses integrated care for comorbidities and is adaptable to various chronic diseases beyond nephrology.
